Lung cancer immunotherapy

S. Peters (Lausanne, Switzerland)

Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!

Session: Imminent global problems in lung cancer require joint action: time for an international alliance!
Session type: Hot topics
Number: 477

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Peters (Lausanne, Switzerland). Lung cancer immunotherapy. International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lung cancer Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term) Year: 2020
Lung cancer Source: Breathe 2016; 12: 392-399 Year: 2016
Lung cancer Source: School Course 2014 - Pulmonary Rehabilitation Year: 2014
Boosting immunotherapy in lung cancer Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer Year: 2017
Lung cancer screening Source: International Congress 2017 – Chinese Programme 2017 Year: 2017
Lung cancer screening Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Lung cancer screening Source: Guideline 2015 Year: 2015
Lung cancer patients Source: Eur Respir Monogr 2021; 90: 165-180 Year: 2021
Lung cancer investigations and treatment Source: Breathe 2011; 7: 313-314 Year: 2011
Immunotherapies for lung cancer Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED Year: 2018
ME9 Boosting immunotherapy in lung cancer Source: Milan 2017 - Educational material Year: 2017